{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:43:56Z","timestamp":1775025836482,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1053\/j.seminoncol.2006.04.021","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T12:43:31Z","timestamp":1150375411000},"page":"22-27","source":"Crossref","is-referenced-by-count":29,"special_numbering":"S8","title":["Anthracycline-Induced Cardiotoxicity in Adult Hematologic Malignancies"],"prefix":"10.1053","volume":"33","author":[{"given":"S.A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2006.04.021_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0268-960X(98)90030-3","article-title":"Anthracyclines in haematology","volume":"12","author":"Johnson","year":"1998","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V60.2.454.454","article-title":"Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia","volume":"60","author":"Yates","year":"1982","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib3","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V90.6.2121","article-title":"Intensifying induction therapy in acute myeloid leukemia","volume":"90","author":"Rowe","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.1998.00948.x","article-title":"A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia","volume":"103","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib5","first-page":"2572","article-title":"Phase I and preliminary phase II evaluation of adriamycin (NSC 123127)","volume":"30","author":"Bonadonna","year":"1970","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib6","first-page":"375","article-title":"Adriamycin (NSC-123127) in the treatment of lymphomas","volume":"6","author":"Coltman","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib7","first-page":"381","article-title":"Combination usage of adriamycin (NSC-123127) in malignant lymphomas","volume":"6","author":"Bonadonna","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","article-title":"Effective treatment of advanced multiple myeloma refractory to alkylating agents","volume":"310","author":"Barlogie","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib12","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib13","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1161\/01.CIR.96.8.2641","article-title":"Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury","volume":"96","author":"Lipshultz","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/annonc\/mdg070","article-title":"Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin\u2019s lymphoma","volume":"14","author":"Limat","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib16","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1200\/JCO.1995.13.11.2827","article-title":"Idarubicin cardiotoxicity","volume":"13","author":"Anderlini","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.bjc.6600346","article-title":"Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients","volume":"86","author":"Nousiainen","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2001.19.1.191","article-title":"Anthracycline-induced clinical heart failure in a cohort of 607 children","volume":"19","author":"Kremer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10428199309087004","article-title":"Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin\u2019s disease in adults","volume":"11","author":"Aviles","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0022-3565(24)39082-2","article-title":"Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice","volume":"294","author":"Weinstein","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib22","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","article-title":"Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults","volume":"22","author":"Hequet","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","article-title":"Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer","volume":"25","author":"Brockstein","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bmt.1704027","article-title":"Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission","volume":"31","author":"Robin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1388-9842(99)00015-X","article-title":"Tailored therapy to hemodynamic goals for advanced heart failure","volume":"1","author":"Stevenson","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","article-title":"Functional monitoring of anthracycline cardiotoxicity","volume":"13","author":"Jensen","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jama.262.7.907","article-title":"Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study","volume":"262","author":"Stewart","year":"1989","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib28","first-page":"273","article-title":"Quality of life in patients with advanced heart failure","volume":"11","author":"Dracup","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heart.87.3.235","article-title":"Health related quality of life in patients with congestive heart failure","volume":"87","author":"Juenger","year":"2002","journal-title":"Heart"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"Randomized comparison of ABVD and MOPP\/ABV hybrid for the treatment of advanced Hodgkin\u2019s disease","volume":"21","author":"Duggan","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2006.04.021_bib31","series-title":"Cancer Management","first-page":"727","article-title":"Multiple myeloma and otherplasma cell dyscrasias","author":"Desikan","year":"2003"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775406002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775406002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:10:27Z","timestamp":1736421027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775406002090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":31,"alternative-id":["S0093775406002090"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2006.04.021","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}